Shares of Nurix Therapeutics rose after the company said it will receive a $15 million license extension fee from Sanofi for its STAT6 program. The stock climbed 11% to $11.76 on Monday. Shares have ...

Fintel reports that on June 2, 2025, Goldman Sachs initiated coverage of Aspen Insurance Holdings (NYSE:AHL) with a Neutral ...